INCB Annual Report 2018

Launched on 5 March 2019

__

 

 

The INCB Annual Report, prepared in accordance with the international drug control treaties, examines the global drug control situation, and makes recommendations to Governments and regional and international organizations.

The thematic chapter of the INCB Annual Report for 2018 focuses on the risks and benefits of medical use of cannabis and looks at legislative developments on the non-medical use of cannabis.

The Report reviews the functioning of the international drug control system, and calls for the international community to urgently provide further support to Afghanistan.

In the report the Board urges governments to address drug-related crime through formal criminal justice responses, with respect for human rights.

The Report is accompanied by a special supplement on the availability of internationally controlled medicines, as well as the 2018 Precursors report.

 

(See the report by chapters, here )



Special Topics:

___________________________________________________________________________________

Thematic Chapter 2018 on

Cannabis and cannabinoids for medical, scientifc and "recreational" use: risks and benefts

عربي 中文 Français Русский Español

___________________________________________________________________________________

Press Kit

عربي 中文 English Français Русский Español

____________________________________________________________________________________

Annual Report 2018

عربي 中文 English Français Русский Español

____________________________________________________________________________________

 

Supplement to Annual Report 2018

 

 

The Board is publishing a special supplement on availability entitled "Progress on ensuring adequate access to international controlled substances for medical and scientific purposes". It looks at what is being done to ensure adequate access and how governments can be further helped to address this situation.

The supplement includes the findings of INCB's first global assessment of access to important psychotropic substances, such as those used to treat anxiety and epilepsy, which shows a growing global consumption gap. The report notes that 80 per cent of people with epilepsy live in low- and middle-income countries, where the level of consumption of essential anti-epileptic medicines under international control remains either low or unknown.

Read More

عر بي 中文 English Français Русский Español

     
     

____________________________________________________________________________________

 

Precursors Annual Report 2018

 

INCB publishes an annual report on the implementation of article 12 of the Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988, on precursors and chemical frequently used in the illicit manufacture of narcotic drugs and psychotropic substances.

Read More

عر بي 中文 English Français Русский Español

     
     
©1995-2019 International Narcotics Control Board